[HBV and HCV co-infections in HIV positive patients in the "HAART era": new challenges].
Co-infections with HIV and HCV/HBV are frequently found due to the similar routes of transmission (sexual, parenteral and vertical). Since the introduction of highly active antiretroviral therapy (HAART) there has been a notably decrease in patients morbidity and mortality, nevertheless with the prolonged survival, many of these patients are at risk of developing chronic complication, secondary to the infection of hepatotropic viruses. End stage liver disease is one of the main causes of morbid-mortality among HIV patients in developed countries. Nowadays there are new available therapies, diagnostic and follow up techniques for HBV and HCV, what provides a better control of both co-infections.
Laufer
Natalia L
NL
Servicio de Infectología, Hospital Juan A. Fernández Buenos Aires. natalialaufer@yahoo.com.ar
Quarleri
Jorge F
JF
Bouzas
Maria B
MB
Perez
Hector M
HM
Salomon
Horacio
H
Cahn
Pedro E
PE
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D023241:Antiretroviral Therapy, Highly Active; D001118:Argentina / Q000453:epidemiology; D005260:Female; D005838:Genotype; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy* / Q000635:transmission; D015497:HIV-1 / Q000187:drug effects*; D016174:Hepacivirus / Q000187:drug effects / Q000235:genetics / Q000254:growth & development; D006515:Hepatitis B virus / Q000187:drug effects / Q000235:genetics / Q000254:growth & development; D019694:Hepatitis B, Chronic / Q000150:complications / Q000188:drug therapy*; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016036:Seroepidemiologic Studies